Riepilogo
pazienti trattati
Qualcuno ha mai tratto beneficio dalle cellule staminali?
Per la prima volta, le cellule staminali del cordone ombelicale sono state utilizzate con successo nel 1988 in Francia. Diversi anni dopo, nel 2007, questo metodo è stato introdotto anche dal Gruppo FamiCord in Polonia. Ad oggi, le cellule staminali del cordone ombelicale sono state trapiantate oltre 40.000 volte in tutto il mondo, salvando vite e salute a molte persone.
Il Gruppo FamiCord offre ai propri clienti trattamenti innovativi con le cellule staminali. Consulta l'elenco completo dei pazienti, affetti da diverse patologie, che ne hanno beneficiato.
Elenco dei pazienti
| NO. | Fonte | Tipo di fonte | Diagnosi | Settore medico | Anno di applicazione | Terapia | Paese | Età del destinatario |
|---|---|---|---|---|---|---|---|---|
| 2901 | Apheresis | Allogenico | Sindrome mielodisplasica | Ematologia | 2020 | Terapia standard | Poland | 58 |
| 2902 | Apheresis | Allogenico | Sindrome mielodisplasica | Ematologia | 2020 | Terapia standard | Poland | 67 |
| 2903 | Apheresis | Allogenico | Sindrome mielodisplasica | Ematologia | 2020 | Terapia standard | Poland | 47 |
| 2904 | Apheresis | Allogenico | Sindrome mielodisplasica | Ematologia | 2020 | Terapia standard | Poland | 56 |
| 2905 | Apheresis | Allogenico | Sindrome mielodisplasica | Ematologia | 2020 | Terapia standard | Poland | 55 |
| 2906 | Apheresis | Allogenico | Sindrome mielodisplasica | Ematologia | 2020 | Terapia standard | Poland | 64 |
| 2907 | Apheresis | Allogenico | Sindrome mielodisplasica | Ematologia | 2020 | Terapia standard | Poland | 66 |
| 2908 | Apheresis | Allogenico | Sindrome mielodisplasica | Ematologia | 2020 | Terapia standard | Poland | 65 |
| 2909 | Apheresis | Allogenico | Sindrome mielodisplasica | Ematologia | 2020 | Terapia standard | Poland | 63 |
| 2910 | Apheresis | Allogenico | Sindrome mielodisplasica | Ematologia | 2020 | Terapia standard | Poland | 69 |
| 2911 | Apheresis | Allogenico | Sindrome mielodisplasica | Ematologia | 2020 | Terapia standard | Poland | 63 |
| 2912 | Apheresis | Allogenico | Sindrome mielodisplasica | Ematologia | 2020 | Terapia standard | Germania | 73 |
| 2913 | Apheresis | Allogenico | Mielofibrosi | Ematologia | 2020 | Terapia standard | Poland | 63 |
| 2914 | Apheresis | Allogenico | Myelofibrosis With Myeloid Metaplasia | Ematologia | 2020 | Terapia standard | Poland | 69 |
| 2915 | Apheresis | Allogenico | Myelofibrosis With Myeloid Metaplasia | Ematologia | 2020 | Terapia standard | Poland | 70 |
| 2916 | Apheresis | Allogenico | Myelofibrosis With Myeloid Metaplasia | Ematologia | 2020 | Terapia standard | Poland | 63 |
| 2917 | Apheresis | Allogenico | Myelofibrosis With Myeloid Metaplasia | Ematologia | 2020 | Terapia standard | Poland | 62 |
| 2918 | Apheresis | Allogenico | Myelofibrosis With Myeloid Metaplasia | Ematologia | 2020 | Terapia standard | Poland | 43 |
| 2919 | Apheresis | Allogenico | Myeloma Multiplex | Ematologia | 2020 | Terapia standard | Poland | 63 |
| 2920 | Apheresis | Allogenico | Myeloma Multiplex | Ematologia | 2020 | Terapia standard | Poland | 52 |
| 2921 | Apheresis | Allogenico | Myeloproliferative Neoplasms | Ematologia | 2020 | Terapia standard | Poland | 68 |
| 2922 | Apheresis | Allogenico | Myeloproliferative Neoplasms | Ematologia | 2020 | Terapia standard | Poland | 40 |
| 2923 | Apheresis | Allogenico | No Data | Ematologia | 2020 | Terapia standard | Poland | 71 |
| 2924 | Apheresis | Allogenico | No Data | Ematologia | 2020 | Terapia standard | Poland | 64 |
| 2925 | Apheresis | Allogenico | Linfoma non-Hodgkin | Ematologia | 2020 | Terapia standard | Poland | 65 |
| 2926 | Apheresis | Allogenico | Linfoma non-Hodgkin | Ematologia | 2020 | Terapia standard | Poland | 58 |
| 2927 | Apheresis | Allogenico | Linfoma non-Hodgkin | Ematologia | 2020 | Terapia standard | Poland | 63 |
| 2928 | Apheresis | Allogenico | Linfoma non-Hodgkin | Ematologia | 2020 | Terapia standard | Poland | 58 |
| 2929 | Apheresis | Allogenico | Linfoma non-Hodgkin | Ematologia | 2020 | Terapia standard | Poland | 62 |
| 2930 | Apheresis | Allogenico | Linfoma non-Hodgkin | Ematologia | 2020 | Terapia standard | Poland | 53 |
| 2931 | Apheresis | Allogenico | Linfoma non-Hodgkin | Ematologia | 2020 | Terapia standard | Poland | 57 |
| 2932 | Apheresis | Allogenico | Linfoma non-Hodgkin | Ematologia | 2020 | Terapia standard | Poland | 69 |
| 2933 | Apheresis | Allogenico | Linfoma non-Hodgkin | Ematologia | 2020 | Terapia standard | Poland | 62 |
| 2934 | Apheresis | Allogenico | Linfoma non-Hodgkin | Ematologia | 2020 | Terapia standard | Poland | 34 |
| 2935 | Apheresis | Autologo | Linfoma non-Hodgkin | Ematologia | 2020 | Terapia standard | Germania | 42 |
| 2936 | Apheresis | Allogenico | Linfoma non-Hodgkin | Ematologia | 2020 | Terapia standard | Germania | 62 |
| 2937 | Apheresis | Autologo | Non-Hodgkin-Lymphoma-Relapse | Ematologia | 2020 | Terapia standard | Germania | 56 |
| 2938 | Apheresis | Autologo | Non-Hodgkin-Lymphoma-Relapse | Ematologia | 2020 | Terapia standard | Germania | 67 |
| 2939 | Apheresis | Allogenico | Osteomyelofibrosis | Ematologia | 2020 | Terapia standard | Poland | 68 |
| 2940 | Apheresis | Allogenico | Osteomyelofibrosis | Ematologia | 2020 | Terapia standard | Poland | 52 |
| 2941 | Apheresis | Allogenico | Osteomyelofibrosis | Ematologia | 2020 | Terapia standard | Poland | 64 |
| 2942 | Apheresis | Allogenico | Paroxysmal Nocturnal Hemoglobinuria (Pnh) | Ematologia | 2020 | Terapia standard | Poland | 57 |
| 2943 | Apheresis | Allogenico | Perforin Deficiency | Ematologia | 2020 | Terapia standard | Poland | 2 |
| 2944 | Apheresis | Autologo | Primary Central Nervous System Lymphoma | Ematologia | 2020 | Terapia standard | Germania | 59 |
| 2945 | Apheresis | Autologo | Primary Cerebral Diffuse Large B-Cell Lymphoma | Ematologia | 2020 | Terapia standard | Germania | 66 |
| 2946 | Apheresis | Autologo | Primary Cerebral Diffuse Large B-Cell Lymphoma | Ematologia | 2020 | Terapia standard | Germania | 59 |
| 2947 | Apheresis | Allogenico | Mielofibrosi primaria | Ematologia | 2020 | Terapia standard | Poland | 63 |
| 2948 | Apheresis | Allogenico | Mielofibrosi primaria | Ematologia | 2020 | Terapia standard | Poland | 61 |
| 2949 | Apheresis | Allogenico | Mielofibrosi primaria | Ematologia | 2020 | Terapia standard | Poland | 51 |
| 2950 | Apheresis | Allogenico | Mielofibrosi primaria | Ematologia | 2020 | Terapia standard | Poland | 66 |
| 2951 | Apheresis | Allogenico | Mielofibrosi primaria | Ematologia | 2020 | Terapia standard | Poland | 61 |
| 2952 | Apheresis | Allogenico | Mielofibrosi primaria | Ematologia | 2020 | Terapia standard | Germania | 54 |
| 2953 | Apheresis | Allogenico | Mielofibrosi primaria | Ematologia | 2020 | Terapia standard | Germania | 58 |
| 2954 | Apheresis | Allogenico | Purine Nucleoside Phosphorylase Deficiency | Ematologia | 2020 | Terapia standard | Poland | 1 |
| 2955 | Apheresis | Allogenico | Secondary Acute Myeloid Leukemia | Ematologia | 2020 | Terapia standard | Poland | 43 |
| 2956 | Apheresis | Allogenico | Secondary Acute Myeloid Leukemia | Ematologia | 2020 | Terapia standard | Poland | 76 |
| 2957 | Apheresis | Allogenico | Secondary Acute Myeloid Leukemia | Ematologia | 2020 | Terapia standard | Poland | 57 |
| 2958 | Apheresis | Allogenico | Secondary Acute Myeloid Leukemia | Ematologia | 2020 | Terapia standard | Germania | 66 |
| 2959 | Apheresis | Allogenico | Secondary Acute Myeloid Leukemia | Ematologia | 2020 | Terapia standard | Germania | 56 |
| 2960 | Apheresis | Autologo | Secondary B-Cell Non-Hodgkin-Lymphoma | Ematologia | 2020 | Terapia standard | Germania | 73 |
| 2961 | Apheresis | Autologo | Secondary Diffuse Large B-Cell Lymphoma | Ematologia | 2020 | Terapia standard | Germania | 54 |
| 2962 | Apheresis | Allogenico | Anemia aplastica grave | Ematologia | 2020 | Terapia standard | Poland | 9 |
| 2963 | Apheresis | Allogenico | Anemia aplastica grave | Ematologia | 2020 | Terapia standard | Poland | 53 |
| 2964 | Apheresis | Allogenico | Anemia aplastica grave | Ematologia | 2020 | Terapia standard | Poland | 52 |
| 2965 | Apheresis | Allogenico | Immunodeficienza combinata grave | Ematologia | 2020 | Terapia standard | Poland | 2 |
| 2966 | Apheresis | Allogenico | Sezary Syndrome | Ematologia | 2020 | Terapia standard | Poland | 44 |
| 2967 | Apheresis | Allogenico | T-Cell Acute Lymphoblastic Leukemia | Ematologia | 2020 | Terapia standard | Poland | 14 |
| 2968 | Apheresis | Autologo | T-Cell Non-Hodgkin Lymphoma | Ematologia | 2020 | Terapia standard | Germania | 57 |
| 2969 | Apheresis | Autologo | T-Cell Non-Hodgkin Lymphoma | Ematologia | 2020 | Terapia standard | Germania | 29 |
| 2970 | Apheresis | Autologo | T-Cell Non-Hodgkin Lymphoma | Ematologia | 2020 | Terapia standard | Germania | 64 |
| 2971 | Apheresis | Allogenico | T-Cell Non-Hodgkin Lymphoma | Ematologia | 2020 | Terapia standard | Germania | 63 |
| 2972 | Apheresis | Allogenico | T-Cell-Lymphoma | Ematologia | 2020 | Terapia standard | Poland | 29 |
| 2973 | Apheresis | Autologo | T-Cell-Lymphoma | Ematologia | 2020 | Terapia standard | Germania | 51 |
| 2974 | Apheresis | Autologo | T-Cell-Lymphoma | Ematologia | 2020 | Terapia standard | Germania | 60 |
| 2975 | Apheresis | Allogenico | T-Cell-Prolymphocytic Leukemia | Ematologia | 2020 | Terapia standard | Poland | 55 |
| 2976 | Apheresis | Allogenico | T-Cell-Prolymphocytic Leukemia | Ematologia | 2020 | Terapia standard | Poland | 74 |
| 2977 | Apheresis | Allogenico | Β – Thalassemia | Ematologia | 2020 | Terapia standard | Poland | 6 |
| 2978 | Apheresis | Allogenico | Β – Thalassemia Major | Ematologia | 2020 | Terapia standard | Poland | 17 |
| 2979 | Adipose Tissue | Autologo | Alopecia | Dermatology | 2020 | Terapia sperimentale | Poland | 68,5 |
| 2980 | Adipose Tissue | Autologo | Chondromalacia | Ortopedia | 2020 | Terapia sperimentale | Poland | 45,9 |
| 2981 | Adipose Tissue | Autologo | Gonarthrosis | Ortopedia | 2020 | Terapia sperimentale | Poland | 52,8 |
| 2982 | Adipose Tissue | Autologo | Gonarthrosis | Ortopedia | 2020 | Terapia sperimentale | Poland | 63,4 |
| 2983 | Adipose Tissue | Autologo | Gonarthrosis | Ortopedia | 2020 | Terapia sperimentale | Poland | 41,1 |
| 2984 | Adipose Tissue | Autologo | Gonarthrosis | Ortopedia | 2020 | Terapia sperimentale | Poland | 34,8 |
| 2985 | Adipose Tissue | Autologo | Gonarthrosis | Ortopedia | 2020 | Terapia sperimentale | Poland | 48,1 |
| 2986 | Adipose Tissue | Autologo | Gonarthrosis | Ortopedia | 2020 | Terapia sperimentale | Poland | 57,11 |
| 2987 | Adipose Tissue | Autologo | Gonarthrosis | Ortopedia | 2020 | Terapia sperimentale | Poland | 59,8 |
| 2988 | Adipose Tissue | Autologo | Gonarthrosis | Ortopedia | 2020 | Terapia sperimentale | Poland | 35,1 |
| 2989 | Adipose Tissue | Autologo | Gonarthrosis | Ortopedia | 2020 | Terapia sperimentale | Poland | 61,8 |
| 2990 | Adipose Tissue | Autologo | Gonarthrosis | Ortopedia | 2020 | Terapia sperimentale | Poland | 56,5 |
| 2991 | Adipose Tissue | Autologo | Gonarthrosis; Shoulder Osteoarthritis | Ortopedia | 2020 | Terapia sperimentale | Poland | 42,5 |
| 2992 | Adipose Tissue | Autologo | Internal Damage To The Knee Joint | Ortopedia | 2020 | Terapia sperimentale | Poland | 53,6 |
| 2993 | Adipose Tissue | Autologo | Internal Damage To The Knee Joint | Ortopedia | 2020 | Terapia sperimentale | Poland | 49,2 |
| 2994 | Adipose Tissue | Autologo | Omarthrosis | Ortopedia | 2020 | Terapia sperimentale | Poland | 70,1 |
| 2995 | Adipose Tissue | Autologo | Other Acquired Deformities Of The Ankle And Foot | Ortopedia | 2020 | Terapia sperimentale | Poland | 41,6 |
| 2996 | Adipose Tissue | Autologo | Scar | Dermatology | 2020 | Clinical Trial | Poland | no data |
| 2997 | Adipose Tissue | Autologo | Soft Tissue Diseases Related To Use, Overload And Pressure | Ortopedia | 2020 | Terapia sperimentale | Poland | 61,1 |
| 2998 | Tessuto del cordone ombelicale | Allogenico – Non correlato | Limb-Girdle Muscular Dystrophy | Neurologia | 2019 | Terapia sperimentale | Poland | 5,3 |
| 2999 | Tessuto del cordone ombelicale | Allogenico – Non correlato | Acute Graft Versus Host Disease | Ematologia | 2019 | Terapia sperimentale | Poland | 1,9 |
| 3000 | Tessuto del cordone ombelicale | Allogenico – Non correlato | Acute Graft Versus Host Disease | Ematologia | 2019 | Terapia sperimentale | Poland | 6,1 |